Literature DB >> 27327647

Inflammation and the microbiome: implications for depressive disorders.

Shawn Hayley1, Marie-Claude Audet2, Hymie Anisman2.   

Abstract

Inflammatory processes have been linked to depressive illness, possibly being driven by stressful experiences. As well changes in the balance between microbial species compromising the microbiome could be important in precipitating cytokines and other inflammatory factors that, in turn, influence several pathways leading to depression. In particular, hormonal (e.g. glucocorticoids), trophic (e.g. reductions of growth factors) and oxidative stress signaling in the brain can be altered by the inflammatory milieu, including excessive cytokine release, which contribute to the symptoms that characterize a depressed state (e.g. anhedonia, lethargy, disturbed feeding). Identifying the 'signature' of inflammatory changes evident in the microbiome of specific depressed patients could yield important biomarkers to guide the development of personalized approaches to treatment.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27327647     DOI: 10.1016/j.coph.2016.06.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  9 in total

1.  Feasibility of collection and analysis of microbiome data in a longitudinal randomized trial of community gardening.

Authors:  Mireia Gascon; Kylie K Harrall; Alyssa W Beavers; Deborah H Glueck; Maggie A Stanislawski; Katherine Alaimo; Angel Villalobos; James R Hebert; Kelsey Dexter; Kaigang Li; Jill Litt
Journal:  Future Microbiol       Date:  2020-06-04       Impact factor: 3.165

2.  Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Authors:  Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power
Journal:  Can J Psychiatry       Date:  2017-12-11       Impact factor: 4.356

Review 3.  Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Authors:  Pio Conti; Alessandro Caraffa; Gianpaolo Ronconi; Chiara M Conti; Spiros K Kritas; Filiberto Mastrangelo; Lucia Tettamanti; Theoharis C Theoharides
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

4.  Impacts of canine distemper virus infection on the giant panda population from the perspective of gut microbiota.

Authors:  Na Zhao; Meng Li; Jing Luo; Supen Wang; Shelan Liu; Shan Wang; Wenting Lyu; Lin Chen; Wen Su; Hua Ding; Hongxuan He
Journal:  Sci Rep       Date:  2017-01-04       Impact factor: 4.379

5.  Using Gene Expression Analysis to Examine Changes in Loneliness, Depression and Systemic Inflammation in Lonely Chronically Ill Older Adults.

Authors:  Laurie A Theeke; Jennifer A Mallow; Julie Moore; Ann McBurney; Reyna VanGilder; Taura Barr; Elliott Theeke; Stephanie Rellick; Ashley Petrone
Journal:  Open J Nurs       Date:  2016-08-31

6.  Associations between Depression, Depressive Symptoms, and Incidence of Dementia in Latin America: A 10/66 Dementia Research Group Study.

Authors:  Lena Johansson; Mariella Guerra; Martin Prince; Helena Hörder; Hanna Falk; Brendon Stubbs; A Matthew Prina
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 7.  Gut Biofactory-Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review.

Authors:  Karolina Skonieczna-Żydecka; Karolina Jakubczyk; Dominika Maciejewska-Markiewicz; Katarzyna Janda; Karolina Kaźmierczak-Siedlecka; Mariusz Kaczmarczyk; Igor Łoniewski; Wojciech Marlicz
Journal:  Nutrients       Date:  2020-11-01       Impact factor: 5.717

Review 8.  Affective immunology: where emotions and the immune response converge.

Authors:  Fulvio D'Acquisto
Journal:  Dialogues Clin Neurosci       Date:  2017-03       Impact factor: 5.986

Review 9.  The Developing Microbiome From Birth to 3 Years: The Gut-Brain Axis and Neurodevelopmental Outcomes.

Authors:  Hannah E Laue; Modupe O Coker; Juliette C Madan
Journal:  Front Pediatr       Date:  2022-03-07       Impact factor: 3.569

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.